FibroGen once again has disappointing news to share from a clinical trial, this time from a study of an experimental treatment for Duchenne muscular dystrophy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,